title: Fabry disease: dose matters.
authors.affiliation: Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; and.
authors.forename: David G
authors.initials: DG
authors.lastname: Warnock
authors.forename: Michael
authors.initials: M
authors.lastname: Mauer
mesh_terms: D056947:Enzyme Replacement Therapy; D000795:Fabry Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000627:therapeutic use*; D008297:Male; D000519:alpha-Galactosidase / Q000627:therapeutic use*
chemical_list: D007527:Isoenzymes; D000519:alpha-Galactosidase; C459420:agalsidase beta
keywords: chronic kidney disease; genetic renal disease; proteinuria